ST
Simon Turner
Partner
Sofinnova Partners
About
Category: Business & Leadership
Track: Startups
Industry: Venture Capital & Private Equity
Country: United Kingdom
Description
AI is changing both the pace and the possibilities of modern biology. From protein folding to drug discovery, machine learning is unlocking insights once out of reach. This panel brings together pioneers at the intersection of computation, life sciences, and the investors backing them to explore how algorithms are transforming research, redefining biotech company-building, and reshaping how we think about disease. Join us for breakfast as we unpack what it really means to go from code to cure — and what’s coming next.
About
Category: Business & Leadership
Track: Startups
Industry: Venture Capital & Private Equity
Country: United Kingdom